Evidence map›Paper›PMID 40149716›Full record

ArticleBiomedicines2025

Biomarker-Based Nomogram to Predict Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer.

Meritxell Pérez, Juan José Lozano, Mercedes Ingelmo-Torres, Montserrat Domenech, Caterina Fernández Ramón, J Alfred Witjes, Antoine G van der Heijden, Maria José Requena, Antonio Coy, Ricard Calderon and 4 more

Erratum issuedAbstract read
In one paragraph

Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Meritxell PérezDepartment of Urology, Hospital Universitari Terrassa, 08221 Terrassa, Spain.
Juan José LozanoPlataforma Bioinformatica, Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas (CIBERehd), Hospital Clínic de Barcelona, 08036 Barcelona, Spain.
Mercedes Ingelmo-TorresDepartment of Urology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic de Barcelona, University of Barcelona, 08036 Barcelona, Spain.
Montserrat DomenechMedical Oncology Department, Fundació Althaia, Xarxa Assintencial Universitària de Manresa, 08242 Manresa, Spain.
Caterina Fernández RamónUrology Department, Fundació Althaia, Xarxa Assintencial Universitària de Manresa, 08242 Manresa, Spain.
J Alfred WitjesDepartment of Urology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
Antoine G van der HeijdenDepartment of Urology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.ORCID 0000-0002-8839-8601
Maria José RequenaDepartment of Urology, Reina Sofía University Hospital, IMIBIC, Cordoba University, 14014 Córdoba, Spain.
Antonio CoyFundación Instituto Valenciano de Oncologia (IVO), 46009 Valencia, Spain.ORCID 0000-0002-5232-8126
Ricard CalderonDepartment of Urology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic de Barcelona, University of Barcelona, 08036 Barcelona, Spain.
Begoña MelladoTranslational Genomics and Targeted Therapeutics in Solid Tumors, Medical Oncology Department, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Hospital Clínic de Barcelona, 08036 Barcelona, Spain.ORCID 0000-0002-8088-5966
Antonio AlcarazUro-Oncology Unit, Department of Urology, Hospital Clinic de Barcelona, 08036 Barcelona, Spain.
Antoni VilasecaUro-Oncology Unit, Department of Urology, Hospital Clinic de Barcelona, 08036 Barcelona, Spain.ORCID 0000-0003-0160-620X
Maria J RibalUro-Oncology Unit, Department of Urology, Hospital Clinic de Barcelona, 08036 Barcelona, Spain.ORCID 0000-0001-8142-5382

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bladder cancergene expression profileneoadjuvant chemotherapyprognostic modelresponse prediction

Identifiers

PMID40149716
PMCPMC11939915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.